This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignee: Celgene Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Farid Van Der Mei: Innovator in Pharmaceutical Research
Introduction
Farid Van Der Mei is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of MK2 inhibitors. His work is instrumental in advancing therapeutic options for various medical conditions.
Latest Patents
Farid holds a patent for "MK2 INHIBITORS AND USES THEREOF." This patent represents his innovative approach to targeting specific pathways in disease processes, showcasing his expertise in medicinal chemistry.
Career Highlights
Farid is currently employed at Celgene Corporation, a leading biopharmaceutical company known for its focus on innovative therapies. His role at Celgene allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Farid has worked alongside talented colleagues such as Xirui Hu and Lixin Qiao. Their combined efforts in research and development have led to advancements in the understanding and treatment of various diseases.
Conclusion
Farid Van Der Mei's contributions to pharmaceutical research and his innovative patent work exemplify the impact of dedicated inventors in the medical field. His ongoing efforts at Celgene Corporation continue to push the boundaries of science and medicine.